Nano-Scale Gene Delivery Systems: Current Technology, Obstacles, and Future Directions

被引:14
作者
Garcia-Guerra, Antonio [1 ]
Dunwell, Thomas L. [2 ]
Trigueros, Sonia [1 ,2 ]
机构
[1] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England
[2] Univ Oxford, Dept Zool, Oxford OX2 6GG, England
基金
英国工程与自然科学研究理事会;
关键词
Gene delivery; transfection; gene therapy; nanotechnology; nano-gene delivery; biological therapy; biomedicine; nanomedicine; FUNCTIONALIZED CARBON NANOTUBES; BLOOD-BRAIN-BARRIER; VIRAL VECTORS; INTRACELLULAR TRAFFICKING; MAGNETIC NANOPARTICLES; POLY(ETHYLENE GLYCOL); LENTIVIRAL VECTORS; THERAPY PROGRESS; PLASMID DNA; IN-VITRO;
D O I
10.2174/0929867325666180108100723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Within the different applications of nanomedicine currently being developed, nano-gene delivery is appearing as an exciting new technique with the possibility to overcome recognised hurdles and several biological and medical needs. The central component of all delivery systems is the requirement for the delivery of genetic material into cells, and for them to eventually reside in the nucleus where their desired function will be exposed. However, genetic material does not passively enter cells; thus, a delivery system is necessary. The emerging field of nano-gene delivery exploits the use of new materials and the properties that arise at the nanometre-scale to produce delivery vectors that can effectively deliver genetic material into a variety of different types of cells. The novel physicochemical properties of the new delivery vectors can be used to address the current challenges existing in nucleic acid delivery in vitro and in vivo. While there is a growing interest in nanostructure-based gene delivery, the field is still in its infancy, and there is yet much to discover about nanostructures and their physicochemical properties in a biological context. We carried out an organised and focused search of bibliographic databases. Our results suggest that despite new breakthroughs in nanostructure synthesis and advanced characterization techniques, we still face many barriers in producing highly efficient and non-toxic delivery systems. In this review, we overview the types of systems currently used for clinical and biomedical research applications along with their advantages and disadvantages, as well as discussing barriers that arise from nano-scale interactions with biological material. In conclusion, we hope that by bringing the far reaching multidisciplinary nature of nano-gene delivery to light, new targeted nanotechnology-bases strategies are developed to overcome the major challenges covered in this review.
引用
收藏
页码:2448 / 2464
页数:17
相关论文
共 113 条
[1]   Adeno-associated virus serotype rh.10 displays strong muscle tropism following intraperitoneal delivery [J].
Ai, Jianzhong ;
Li, Jia ;
Gessler, Dominic J. ;
Su, Qin ;
Wei, Qiang ;
Li, Hong ;
Gao, Guangping .
SCIENTIFIC REPORTS, 2017, 7
[2]   Nonviral Gene Delivery: Principle, Limitations, and Recent Progress [J].
Al-Dosari, Mohammed S. ;
Gao, Xiang .
AAPS JOURNAL, 2009, 11 (04) :671-681
[3]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[4]   DNA electrotransfer:: its principles and an updated review of its therapeutic applications [J].
André, F ;
Mir, LM .
GENE THERAPY, 2004, 11 (Suppl 1) :S33-S42
[5]   Cellular abnormalities of blood vessels as targets in cancer [J].
Baluk, P ;
Hashizume, H ;
McDonald, DM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :102-111
[6]   From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery [J].
Banks, William A. .
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) :275-+
[7]   Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis [J].
Bazzoni, G ;
Dejana, E .
PHYSIOLOGICAL REVIEWS, 2004, 84 (03) :869-901
[8]   The Possible "Proton Sponge" Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH [J].
Benjaminsen, Rikke V. ;
Mattebjerg, Maria A. ;
Henriksen, Jonas R. ;
Moghimi, S. Moein ;
Andresen, Thomas L. .
MOLECULAR THERAPY, 2013, 21 (01) :149-157
[9]   Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection [J].
Biffi, Alessandra ;
Bartholomae, Cynthia C. ;
Cesana, Daniela ;
Cartier, Natalie ;
Aubourg, Patrik ;
Ranzani, Marco ;
Cesani, Martina ;
Benedicenti, Fabrizio ;
Plati, Tiziana ;
Rubagotti, Enrico ;
Merella, Stefania ;
Capotondo, Alessia ;
Sgualdino, Jacopo ;
Zanetti, Gianluigi ;
von Kalle, Christof ;
Schmidt, Manfred ;
Naldini, Luigi ;
Montini, Eugenio .
BLOOD, 2011, 117 (20) :5332-5339
[10]  
Bikram M, 2010, Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof, Patent No. [WO/2010/093420, 2010093420]